Risk stratification and medical therapy of pulmonary arterial hypertension
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Pulmonary arterial hypertension (PAH) remains a severe clinical condition despite the availability over the past 15 years of multiple drugs interfering with the endothelin, nitric oxide and prostacyclin pathways. The recent progress observed in medical therapy of PAH is not, therefore, related to the discovery of new pathways, but to the development of new strategies for combination therapy and on escalation of treatments based on systematic assessment of clinical response. The current treatment strategy is based on the severity of the newly diagnosed PAH patient as assessed by a multiparametric risk stratification approach. Clinical, exercise, right ventricular function and haemodynamic parameters are combined to define a low-, intermediate- or high-risk status according to the expected 1-year mortality. The current treatment algorithm provides the most appropriate initial strategy, including monotherapy, or double or triple combination therapy. Further treatment escalation is required in case low-risk status is not achieved in planned follow-up assessments. Lung transplantation may be required in most advanced cases on maximal medical therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 Time-course of completed randomised controlled trials (RCTs) in pulmonary arterial hypertension (PAH) (n=41) according to treatment strategy. SSc: systemic sclerosis; IPAH: idiopathic PAH. Reproduced and modified from [70] with permission.](https://figures.cochat.ai/paper-figures/44281cb9913845f29b53a42c8e3258e5/risk-stratification-and-medical-therapy-of-pulmonary-arterial-hypertension-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other high-risk profiles include familial PAH, PVOD, CTD-PAH, CTD-PAH associated with concomitant ILD, rapidly progressive disease despite therapy, and development of hemoptysis.(282, 291–293)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In particular, the 2018 World Symposium on Pulmonary Hypertension strongly recommends serial parametric risk assessment.(282)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
The cited source says what the claim attributes to it.
In the citing paper
“The 2018 World Symposium on Pulmonary Hypertension states that the ultimate goal of therapy for patients with PAH is to achieve a low-risk status, assessed either by REVEAL or the ESC/ERS model.(282)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationHaemodynamic definitions and updated clinical classification of pulmonary hypertension
Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01913-2018 · Cited by 3,813
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationBosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Self-citationBarst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. M., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,698
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Self-citationInhaled Iloprost for Severe Pulmonary Hypertension
Olschewski, H., Simonneau, G., Galiè, N., Higenbottam, T., Naeije, R., Rubin, L. J., Nikkho, S., Speich, R., Hoeper, M. M., Behr, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020204 · Cited by 1,783
Self-citationBenza, R. L., Miller, D. P., Gomberg-Maitland, M., Frantz, R. P., Foreman, A. J., Coffey, C. S., Frost, A., Barst, R. J., Badesch, D. B., Elliott, C. G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.898122 · Cited by 1,547
Self-citationChannick, R. N., Simonneau, G., Sitbon, O., Robbins, I. M., Frost, A., Tapson, V. F., Badesch, D. B., Roux, S., Rainisio, M., Bodin, F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06250-x · Cited by 1,534
Self-citation
Research works printed but not linked: 2
- Benza, 2018, Comparison of three assessment strategies as predictors of one-year survival in US pulmonary arterial hypertension (PAH) patients, Am J Respir Crit Care Med, 197, A7649
- Galiè, 2014, AMBITION: a randomised, multicenter study of first-line ambrisentan and tadalafil combination therapy in subjects with pulmonary arterial hypertension (PAH), Eur Respir J, 44, 2916
Cited by
Items 301–400 of 897
Portopulmonary hypertension practice patterns after liver transplantation
Jose, A., Kopras, E. J., Shah, S. A., & Elwing, J. (2022) · Liver Transplantation · doi:10.1002/lt.26575 · Cited by 13
The Lung Transplant Candidate, Indications, Timing, and Selection Criteria
Mannem, H. C., Aversa, M. M., Keller, T., & Kapnadak, S. G. (2023) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.10.001 · Cited by 13
Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy
Kearney, K. L., Brown, K., Celermajer, D. S., Collins, N. J., Cordina, R., Corrigan, C., Dwyer, N., Feenstra, J., Keating, D., KEOGH, A. M., et al. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.10.037 · Cited by 13
Feng, J., Liu, Y., Li, K., & Wu, Y. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125332 · Cited by 13
Lerche, M., Eichstaedt, C. A., Hinderhofer, K., Grünig, E., Tausche, K., Ziemssen, T., Halank, M., Wirtz, H. R. W., & Seyfarth, H. (2019) · Pulmonary Circulation · doi:10.1177/2045894019872192 · Cited by 13
Self-citationThe role of rehabilitation in patients with pulmonary arterial hypertension
Eichstaedt, C. A., Benjamin, N., Xanthouli, P., Marra, A. M., & Grünig, E. (2019) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000609 · Cited by 13
Self-citationIncremental step test in patients with pulmonary hypertension
Vieira, E. B., Arakaki, J. S. O., Corso, S. D., Ivanaga, I. T., Fonseca, A. X. C., Oliveira, R. K. F., Rodrigues-Junior, J., Ferreira, E. V. M., Nery, L. E., & Ramos, R. P. (2019) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2019.103307 · Cited by 13
CASCINO, T. M., Ashur, C., Richardson, C. R., Jackson, E. A., & McLaughlin, V. V. (2020) · Pulmonary Circulation · doi:10.1177/2045894020974926 · Cited by 13
Self-citationSavale, L., Vuillard, C., Pichon, J., Boucly, A., Roche, A., Jevnikar, M., Ebstein, N., Jaïs, X., Pavec, J. L., Montani, D., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00466-2021 · Cited by 13
Rahaghi, F., Balasubramanian, V. P., Bourge, R. C., Burger, C. D., Chakinala, M. M., Eggert, M. S., Elwing, J., Feldman, J., King, C. S., Klinger, J. R., et al. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12055 · Cited by 13
Self-citationBadagliacca, R., Papa, S., D'Alto, M., Ghio, S., Agostoni, P., Ameri, P., Argiento, P., Brunetti, N. D., Casamassima, V., Casu, G., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02276-2021 · Cited by 13
Tamura, Y., Tamura, Y., Taniguchi, Y., Tsujino, I., Inami, T., Matsubara, H., Shigeta, A., Sugiyama, Y., Adachi, S., Abe, K., et al. (2022) · Circulation Reports · doi:10.1253/circrep.cr-22-0098 · Cited by 13
Self-citationRisk assessment in precapillary pulmonary hypertension: a comparative analysis
Sonnweber, T., Schneider, E.-M., Nairz, M., Theurl, I., Weiß, G., Tymoszuk, P., & Löffler‐Ragg, J. (2021) · Respiratory Research · doi:10.1186/s12931-021-01624-z · Cited by 13
Ruopp, N. F., & Farber, H. W. (2019) · Circulation · doi:10.1161/circulationaha.119.040292 · Cited by 13
Hasan, H., Chouvarine, P., Diekmann, F., Diedrich, N., Köestenberger, M., & Hansmann, G. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13835 · Cited by 12
Shafeghat, M., Raza, Y., Catania, R., Rahsepar, A. A., Tilkens, B. L., Cuttica, M. J., Freed, B. H., Dai, J., Zhao, Y., & Carr, J. (2025) · Biomedicines · doi:10.3390/biomedicines13071773 · Cited by 12
Aldalaan, A. M., Saleemi, S., Weheba, I., Abdelsayed, A., Al-Eid, M., Alzubi, F., Zaytoun, H., & Alharbi, N. (2020) · Respirology · doi:10.1111/resp.13879 · Cited by 12
Wilson, M. A., Anguiano, R. H., Awdish, R., Coons, J. C., Kimber, A., Morrison, M. A., Paulus, S., Schmit, A., Spexarth, F. C., Swetz, K. M., et al. (2021) · Pulmonary Circulation · doi:10.1002/pul2.12003 · Cited by 12
Current status of pulmonary artery denervation
Davies, M. G., Miserlis, D., & Hart, J. P. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.972256 · Cited by 12
Spilimbergo, F. B., Rodrigues, R. P., Dias‐Pinto, M. C., Blanco, D. C., Barbieri, G. M., Andrade‐Lima, M., Fagundes, A. L., Gazzana, M. B., Roncato, G., Mello, M. M., et al. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12193 · Cited by 12
Zhang, J., Kan, J., Wei, Y., Zhang, C., Yang, Z., Gu, H., Fan, F., Gu, H., Wang, Q., Xie, D., et al. (2023) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2023.03.015 · Cited by 12
Benza, R. L., Adamson, P. B., Bhatt, D. L., Frick, F., Olsson, G., Bergh, N., & Dahlöf, B. (2024) · Pulmonary Circulation · doi:10.1002/pul2.12323 · Cited by 12
Prognostic Value of Plasma Immunoglobulin G N-Glycome Traits in Pulmonary Arterial Hypertension
Zhang, Z., Liu, C., Ma, J., Ma, J.-S., Wang, J., Li, R., Lu, D., Zhou, Y., Lian, T., Zhang, S.-J., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.05.077 · Cited by 12
Self-citationTreating Pulmonary Arterial Hypertension With Exercise: The Role of Rehabilitative Medicine
Johnson, M., & Peacock, A. J. (2019) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-18.2.56 · Cited by 12
Corrêa, R. D. A., Pereira, M. C., Bizzi, M. F., de Oliveira, R. W. R., Rezende, C. F., de Oliveira, B. C. M. T., Heaney, A., McKenna, S. P., & Ribeiro‐Oliveira, A. (2020) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-020-00209-6 · Cited by 12
Screening for pulmonary arterial hypertension in systemic sclerosis: Now or never!
Brown, Z., & Nikpour, M. (2020) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2020.19114 · Cited by 12
The Role of Exercise Testing in Pulmonary Vascular Disease
Systrom, D., Warren, A., & Naeije, R. (2021) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.11.003 · Cited by 12
Disease-specific platelet signaling defects in idiopathic pulmonary arterial hypertension
Aulak, K. S., Abdi, S. A., Li, L., Crabb, J. S., Ghosh, A., Willard, B. B., Stuehr, D. J., Crabb, J. W., Dweik, R. A., & Tonelli, A. R. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00500.2020 · Cited by 12
Lan, W., Deng, Y., Wei, B., Huang, K., Dai, P., Xie, S., & Wu, D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.843606 · Cited by 12
Nagata, J., Sekine, A., Tanabe, N., Taniguchi, Y., Ishida, K., Shiko, Y., Sakao, S., Tatsumi, K., & Suzuki, T. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02073-0 · Cited by 12
Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019
Goncharova, E. A., Chan, S. Y., Ventetuolo, C. E., Weißmann, N., SCHERMULY, R. T., Mullin, C. J., & Gladwin, M. T. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0576up · Cited by 12
Does combination therapy work in chronic thromboembolic pulmonary hypertension?
van Thor, M. C. J., Snijder, R. J., Kelder, J. C., Mager, J. J., & Post, M. C. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100544 · Cited by 12
The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan
Takahashi, Y., Yamamoto, K., Sakao, S., Takeuchi, T., Suda, R., Tanabe, N., & Tatsumi, K. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01452-3 · Cited by 12
Cardiovascular Diseases That Have Emerged From the Darkness
Maron, B. J., Maron, M. S., Maurer, M. S., Rowin, E. J., Maron, B. A., & Galiè, N. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021095 · Cited by 12
Self-citationGeschlechterspezifische Aspekte kardiovaskulärer Erkrankungen
Baessler, A., Bauer, P., Becker, M., Berrisch-Rahmel, S., Goldmann, B. U., Grünig, E., Hamm, C., Meder, B., Kindermann, I., Ong, P., et al. (2024) · Die Kardiologie · doi:10.1007/s12181-024-00694-9 · Cited by 11
Self-citationLange, T. J., Subías, P. E., Muller, A., Fernandes, C., Fontana, M., Remeňová, T., Söderberg, S., & Gaine, S. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02946-2 · Cited by 11
Callejo, M., Blanco, I., Barberà, J. A., & Pérez‐Vizcaíno, F. (2021) · European Respiratory Journal · doi:10.1183/13993003.01204-2021 · Cited by 11
How We Would Treat Our Own Pulmonary Hypertension if We Needed to Undergo Cardiac Surgery
Diaz-Rodriguez, N., Nyhan, S. M., Kolb, T. M., & Steppan, J. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.09.030 · Cited by 11
Lichtblau, M., Saxer, S., Müller, J., Appenzeller, P., Berlier, C., Schneider, S., Mayer, L. C., Furian, M., Schwarz, E. I., Swenson, E. R., et al. (2023) · Pulmonology · doi:10.1016/j.pulmoe.2022.11.004 · Cited by 11
Yang, H., Wang, G., Zhu, P.-C., & Xiao, Z. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113555 · Cited by 11
CircDiaph3 influences PASMC apoptosis by regulating PI3K/AKT/mTOR pathway through IGF1R
Liu, G., Zhang, S., Yang, S., Shen, C., Shi, C., & Diao, W. (2023) · 3 Biotech · doi:10.1007/s13205-023-03739-0 · Cited by 11
Shafran, I. H., Probst, V., Panzenboeck, A., Sadushi‐Kolici, R., Gerges, C., Wolzt, M., Segel, M. J., Celermajer, D. S., Lang, I. M., & Skoro‐Sajer, N. (2024) · JACC Heart Failure · doi:10.1016/j.jchf.2024.02.013 · Cited by 11
Orozco‐Levi, M., Souza, R., Bluro, I. M., Harley, J., Oropeza, J. L. H., Lescano, A. J., Meyer, G. M. B., Pineda, T., Ramirez, A., Small, M., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-087263 · Cited by 11
Self-citationPrognostic biomarkers in pediatric pulmonary arterial hypertension
Ploegstra, M., & Berger, R. M. F. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-374 · Cited by 11
An update on the diagnosis and treatment of pediatric pulmonary hypertension
Olguntürk, R. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1757071 · Cited by 11
Kato, M., Sugimoto, A., & Atsumi, T. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1825940 · Cited by 11
the Japan Pulmonary Hypertension Registry (JAPHR) Network, Tamura, Y., Kumamaru, H., Abe, K., Satoh, T., Miyata, H., Ogawa, A., Tanabe, N., Hatano, M., Yao, A., et al. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01398-6 · Cited by 11
Self-citationZhong, D., Zhang, Y., Jin, Q., Zhang, X., Zhang, F., Chen, D., Guan, L., Zhou, D., & Ge, J. (2021) · Pulmonary Circulation · doi:10.1177/20458940211051292 · Cited by 11
Proteomic analysis of pulmonary arterial hypertension
Qin, X., Li, T., Sun, W., Guo, X., & Fang, Q. (2021) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223211047304 · Cited by 11
The use of pulmonary arterial hypertension therapies in Eisenmenger syndrome
Arvanitaki, A., & Diller, G. (2021) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2021.2021069 · Cited by 11
Clinician's Corner: Counseling Patients with Pulmonary Vascular Disease Traveling to High Altitude
Ulrich, S., Lichtblau, M., Schneider, S., Saxer, S., & Bloch, K. E. (2022) · High Altitude Medicine & Biology · doi:10.1089/ham.2022.0051 · Cited by 11
Jacob, B., Huazheng, H., & Congzhao, H. (2023) · Journal Markcount Finance · doi:10.55849/jmf.v1i1.53 · Cited by 11
Nakayama, M., Konishi, M., Sugano, T., Okamura, M., Gohbara, M., Iwata, K., Nakayama, N., Akiyama, E., Komura, N., Nitta, M., et al. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.06.006 · Cited by 11
Anticoagulation in pulmonary arterial hypertension: a decision analysis
Jose, A., Eckman, M. H., & Elwing, J. (2019) · Pulmonary Circulation · doi:10.1177/2045894019895451 · Cited by 11
Gillmeyer, K. R., Miller, D. R., Glickman, M. E., Qian, S. X., Klings, E. S., Maron, B. A., Hanlon, J. T., Rinne, S. T., & Wiener, R. S. (2021) · Pulmonary Circulation · doi:10.1177/20458940211001714 · Cited by 11
Schoenberg, N. C., & Farber, H. W. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202008-3313ed · Cited by 11
Imaging risk in pulmonary arterial hypertension
Badagliacca, R., & Vizza, C. D. (2020) · European Respiratory Journal · doi:10.1183/13993003.02313-2020 · Cited by 11
Ishiguro, M., Takeuchi, K., Kikuchi, H., Goda, A., Inami, T., Tamura, Y., Kataoka, M., Fukuda, K., & Satoh, T. (2020) · Circulation Reports · doi:10.1253/circrep.cr-20-0006 · Cited by 10
Self-citationFarber, H. W., Chakinala, M. M., Cho, M., Frantz, R. P., Frick, A., LANCASTER, L. H., Milligan, S., Oudiz, R. J., Panjabi, S. S., Tsang, Y., et al. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12258 · Cited by 10
Self-citationGarcia, A. R., Blanco, I., Ramon, L., Pérez-Sagredo, J., Guerra-Ramos, F. J., Martín‐Ontiyuelo, C., Tura-Ceide, O., Pastor‐Pérez, F. J., Subías, P. E., & Barberà, J. A. (2023) · Respiratory Research · doi:10.1186/s12931-023-02531-1 · Cited by 10
Hoyos, R., Lichtblau, M., Cajamarca, E., Mayer, L. C., Schwarz, E. I., & Ulrich, S. (2024) · Pulmonary Circulation · doi:10.1002/pul2.12404 · Cited by 10
Frank, B. S., Gentzler, E., Avitabile, C. M., Miller‐Reed, K., Pan, Z., Rosenzweig, E. B., Ivy, D. D., & Krishnan, U. (2024) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2024.114221 · Cited by 10
Equivalency of Multiple Biomarkers to Clinical Pulmonary Arterial Hypertension Survival Risk Models
Griffiths, M., Simpson, C. E., Yang, J., Vaidya, D. M., Nies, M., Brandal, S., D’Amico, R., Hassoun, P. M., Ivy, D. D., Austin, E. D., et al. (2024) · CHEST Journal · doi:10.1016/j.chest.2024.06.3824 · Cited by 10
Diagnosis and Management of Pulmonary Hypertension: New Insights
Ntiloudi, D., Kasinos, N., Kalesi, A. E., Vagenakis, G. A., Theodosis-Georgilas, A., & Rammos, S. (2024) · Diagnostics · doi:10.3390/diagnostics14182052 · Cited by 10
Costa, G. O. S., Ramos, R. P., Oliveira, R. K. F., Cepêda, A., Vieira, E. B., Ivanaga, I. T., Ferreira, E. V. M., & Arakaki, J. S. O. (2019) · Pulmonary Circulation · doi:10.1177/2045894019888422 · Cited by 10
Comprehensive identification of signaling pathways for idiopathic pulmonary arterial hypertension
Liu, B., Zhu, L., Yuan, P., Marsboom, G., Hong, Z., Liu, J., Zhang, P., & Hu, Q. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00382.2019 · Cited by 10
Shmalts, A. A., & Gorbachevsky, S. V. (2020) · Terapevticheskii arkhiv · doi:10.26442/00403660.2020.12.000840 · Cited by 10
Calcaterra, G., Bassareo, P. P., Barillà, F., Martino, F., Fanos, V., Fedele, F., & Romeo, F. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1695770 · Cited by 10
Kim, N. H., Fisher, M., Poch, D. S., Zhao, C., Shah, M., & Bartolome, S. (2020) · Pulmonary Circulation · doi:10.1177/2045894020935291 · Cited by 10
Goten, C., Usui, S., Takashima, S., Inoue, O., Okada, H., Shimojima, M., Sakata, K., Kawashiri, M., Kaneko, S., & Takamura, M. (2021) · Pulmonary Circulation · doi:10.1177/2045894021990525 · Cited by 10
Leandro, H. I. C., Koshevaya, E. G., Mitrofanova, L. B., Vakhrushev, A. D., Goncharova, N. S., Korobchenko, L. E., Andreeva, E. M., Lebedev, D. S., & Mikhaylov, E. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168788 · Cited by 10
Biomarkers in pulmonary arterial hypertension: Moving closer toward precision medicine?
Kanwar, M. K. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.02.020 · Cited by 10
Sweatt, A. J., Reddy, R. M., Rahaghi, F. N., Al‐Naamani, N., & American Thoracic Society Pulmonary Circulation Assembly Early Career Working Group (2021) · Pulmonary Circulation · doi:10.1177/20458940211040713 · Cited by 9
Hu, X., Ding, N., Songchen, W., Wang, R., Chen, J., Zhong, A., Nan, J., Zuo, Y., Huang, H., & Tian, D. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10080350 · Cited by 9
Wang, S., Yan, Y., Zhang, J., Yuan, P., Luo, C., Qiu, H., Li, H., Xu, J., Wang, L., Li, T., et al. (2023) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12347 · Cited by 9
Chai, Y., Gu, X., Zhang, H., Xu, X., & Chen, L. (2024) · Aging · doi:10.18632/aging.205468 · Cited by 9
Toma, M., Savonitto, G., Lombardi, C. M., Airò, E., Driussi, M., Gentile, P., Howard, L., Moschella, M., Poi, E. D., Pagnesi, M., et al. (2024) · Clinical Research in Cardiology · doi:10.1007/s00392-024-02448-9 · Cited by 9
Zhang, S., Gao, L., Li, S., Luo, M., Xi, Q., Lin, P., Zhao, Z., Zhao, Q., Yang, T., Zeng, Q., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02476-9 · Cited by 9
Pharmacologic therapy for pulmonary artery hypertension
Nair, A. P. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000796 · Cited by 9
Ţilea, I., Petra, D. N., Şerban, R. C., Gabor, M. R., Tilinca, M. C., Azamfirei, L., & Varga, A. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s318343 · Cited by 9
Rezende, C. F., Mancuzo, E. V., & Corrêa, R. D. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268839 · Cited by 9
Guimarães‐Ervilha, L. O., Soares, L. L., Bento, I. P. D. S., Carvalho, R. P. R., Lima, T. I., Dias, F. C. R., Bastos, D. S. S., Cossolin, J. F. S., Souza, A. C. F., Reis, E. C. C., et al. (2023) · Microscopy and Microanalysis · doi:10.1093/micmic/ozac037 · Cited by 9
Karampour, S. O., Sugarman, J. A., Alkhodair, A. M., Liang, J., Mielniczuk, L. M., Hambly, N., Helmersen, D., Hirani, N., Thakrar, M. V., Varughese, R. A., et al. (2023) · CJC Open · doi:10.1016/j.cjco.2023.04.005 · Cited by 9
Naranjo, M., Rosenzweig, E. B., Hemnes, A. R., Jacob, M. S., Desai, A. A., Hill, N. S., Larive, A. B., Finet, J. E., Leopold, J. A., Horn, E. M., et al. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12281 · Cited by 9
Self-citationPlunkett, M. J., Sayegh, A. L. C., McWilliams, T. J., Sithamparanathan, S., Paton, J. F. R., & Fisher, J. P. (2023) · European Respiratory Journal · doi:10.1183/13993003.00952-2023 · Cited by 9
Kramer, T., Nattmann, P., Gerhardt, F., Stafiej, P., Dumitrescu, D., ten Freyhaus, H., Wißmüller, M., Hohmann, C., Baldus, S. E., & Rosenkranz, S. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14611 · Cited by 9
Cardiac catheterization in pulmonary hypertension: doing it right, with a catheter on the left
Hansmann, G., Rich, S., & Maron, B. A. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-483 · Cited by 9
Evidence synthesis in pulmonary arterial hypertension: a systematic review and critical appraisal
Schlueter, M., Beaudet, A., Davies, E. W., Gurung, B., & Karabis, A. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-01241-4 · Cited by 9
Right heart catheterization for pulmonary hypertension during the coronavirus disease 2019 pandemic
Qaiser, K. N., Lane, J. E., & Tonelli, A. R. (2020) · Pulmonary Circulation · doi:10.1177/2045894020948783 · Cited by 9
Grignola, J. C., Domingo, E., López‐Meseguer, M., Trujillo, P., Bravo, C., Pérez‐Hoyos, S., & Román, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.631326 · Cited by 9
Epoprostenol for the treatment of pulmonary arterial hypertension
Ropero, M. J. C., Cruz‐Utrilla, A., & Escribano-Subias, M. P. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1929925 · Cited by 9
Towards Treatable Traits for Pulmonary Fibrosis
Hoffman, T. W., & Grutters, J. C. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081275 · Cited by 9
Youssef, D. E., Handler, S. S., Richards, S., Sheppard, C., Smith, J., Tillman, K. A., Pietrosanu, M., Kirkpatrick, E. C., & Bates, A. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1055131 · Cited by 9
The role of riociguat in combination therapies for pulmonary arterial hypertension
Rahaghi, F., Trivieri, M. G., & Sahay, S. (2023) · Respiratory Medicine · doi:10.1016/j.rmed.2023.107196 · Cited by 9
McConnell, J. W., Tsang, Y., Pruett, J., & Drake, W. B. (2020) · Pulmonary Circulation · doi:10.1177/2045894020911831 · Cited by 9
Monotherapy in patients with pulmonary arterial hypertension at four German PH centres
Stubbe, B., Seyfarth, H., Kleymann, J., Halank, M., Ghorani, H. A., Obst, A., Desole, S., Ewert, R., & Opitz, C. F. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01499-2 · Cited by 9
Humbert, M. J. C., & Lau, E. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.07.005 · Cited by 9
Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective
Humbert, M. J. C., & Lau, E. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202012-4350ed · Cited by 9
Leong, K., Howard, L., Giudice, F. L., Davies, R. J., Haji, G., Gibbs, S., & Gopalan, D. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12116 · Cited by 8
Pawar, S., Khan, N., Salam, A., Joshi, M., Saravanan, P. B., & Pandey, S. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101635 · Cited by 8
Metadata
- Authors
- Galiè, N., Channick, R. N., Frantz, R. P., Grünig, E., Jing, Z. C., Moiseeva, O., Preston, I. R., Pulido, T., Safdar, Z., Tamura, Y., & McLaughlin, V. V.
- Affiliations
- University of Bologna (IT)
- Harvard University (US)
- Mayo Clinic (US)
- University Hospital Heidelberg (DE)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Tufts University (US)
- Houston Methodist (US)
- International University of Health and Welfare (JP)
- University of Michigan (US)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801889
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351343
- OpenAlex
- W2904385559
- Cited by
- 819
- References
- 88
- Citations by year
- 2026: 32 · 2025: 46 · 2024: 101 · 2023: 108 · 2022: 174 · 2021: 169 · 2020: 128 · 2019: 58
- FWCI
- 15.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, other-oa)
- Funders
- Japan Society for the Promotion of Science (18K08183)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- pulmonary arterial hypertension, risk stratification, medical therapy, combination therapy, treatment escalation, endothelin receptor antagonists, phosphodiesterase-5 inhibitors, prostacyclin analogues, right ventricular function, exercise capacity, one-year mortality, lung transplantation, treatment algorithm
- MeSH terms
- Pulmonary Arterial Hypertension, Calcium Channel Blockers, Humans, Randomized Controlled Trials as Topic, Lung Transplantation, Practice Guidelines as Topic, Risk Assessment, Phosphodiesterase 5 Inhibitors, Endothelin Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.